For a product to stand out in the flooded nutraceutical market, differentiation through clinical substantiation is key; however, many brands view this as a risk due to the high upfront costs and the lack of a guaranteed positive outcome. We discussed the future of clinical trials and how Radicle Science's technology-based platform aims to make them more accessible to everyone with Pelin Wood Thorogood, the company's Co-Founder and Executive Chairwoman.

Highlights:

00:00 Introduction
03:43 Radicle Science background
10:20 The need for alternate clinical trials design
12:59 Studies on ingredients vs. finished products
17:53 Radicle Science business model & trial design
21:11 Clinical trial platform & how it works
25:56 Trial range
28:10 Client case study
33:30 Investing in clinicals before going to market
38:15 Using the clinical data in marketing
41:02 Targeting specific subpopulations
48:10 Recognition within the industry
49:00 Justifying the investment
51:25 How marketing and clinical trials will evolve in the future
58:30 What's next for Radicle Science?